The calendar-year first quarter proved challenging for some major publicly held instrument and laboratory product companies. In general, industrial end-markets were soft, US and European academic and government spending remained constrained, and a weaker yen hurt sales and profitability. In addition, Bruker and PerkinElmer experienced unexpected events related to operational issues and weaker-than-expected sales in […]
Company Announcements Bruker named Juergen Srega president of the Bruker CALID Group in January. He served as vice president and general manager, Biomarkers, at BRAHMS, a Thermo Fisher Scientific company, from 2011 to 2012. In March, Veolia Environnement and bioMérieux announced a research partnership to develop an innovative technology for the continuous monitoring of the […]
First quarter revenue growth for IBO’s Laboratory Instrument Sales Index slowed to 0.7%, 1.9% excluding currency, to $5,912 million. Operating profit declined 2.9% to $1,215 million, and operating margin fell 80 basis points to 17.9% of sales. Financial estimates are included for Oxford Instruments, Spectris and Tecan, which have yet to report first quarter financial […]
Instrument and lab product company executives appear more optimistic about sales prospects now than they did in fall 2012, according to the latest results of the IBO Business Climate Survey. This is despite the US budget sequestration and recent downgrade in expectations for world GDP growth by the International Monetary Fund (IMF). In April, the […]
Sustained quantitative easing measures in the US, Japan and China, along with better-than-expected earnings reports and jobless claims toward the end of April, helped elevate the Dow Jones Industrial Average and S&P 500 to new highs this month. However, equity markets came under pressure earlier in the month due to slower manufacturing and durable goods […]
Company Announcements Sigma-Aldrich’s BioReliance business named Archie Cullen, former vice president of Sigma-Aldrich SAFC, president in March. BioReliance agreed to acquire the colonies required for the Big Blue transgenic rodent mutation assay, the first in vivo genetic toxicology mutation assays to be approved by the Organization for Economic Co-operation and Development, and obtain a license […]
Company Announcements Halma acquired in January Hong Kong’s Thinketron Precision Equipment, its Chinese subsidiary Baoding Longer Precision Pump and US subsidiary Langer Instruments for £23.7 million ($37.6 million) and deferred consideration. Longer Pump manufacturers and markets peristaltic, syringe and gear pumps used in lab, medical and industrial applications. Halma announced that its Health & Analysis […]
The US federal government’s primary science R&D agencies must deal with less funding for fiscal 2013 (FY13) (October 2012–September 2013) in the wake of the finalized budget. The budgets for most science R&D agencies are cut by an automatic 5.0% as part of the sequestration (see IBO 3/15/13), in addition to any reductions from FY12 […]
Fourth-quarter 2012 IBO Lab Equipment/Consumables Sales Index revenues grew 2.1%, 3.4% excluding currency, to $4,316 million. Operating profit advanced 0.4% to $735 million. Operating margin declined 50 basis points to 17.9% of sales. Full-year 2012 Index sales grew 1.6%, 2.6% excluding currency, to $16,472 million. Adjusted operating profit rose 2.7% to $2,889 million. Operating margin […]
Santa Clara, CA 4/9/13—Affymetrix has announced that it expects first-quarter revenues of $78 million, including eBioscience revenue of $19 million. “Our revenues for the first quarter were below expectations, primarily due to continued headwinds in our gene expression business across all regions, in particular Japan, where we came in significantly short of plan,” stated Affymetrix […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
